These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 871415)

  • 1. Evidence that washed human platelets possess factor-X activator activity.
    Semeraro N; Vermylen J
    Br J Haematol; 1977 May; 36(1):107-15. PubMed ID: 871415
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of activated human platelets in prothrombin and factor X activation.
    Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF
    Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
    Miletich JP; Majerus DW; Majerus PW
    J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified Stypven test for the determination of platelet factor 3.
    MacKenzie RD; Blohm TR; Auxier EM
    Am J Clin Pathol; 1971 May; 55(5):551-4. PubMed ID: 5104499
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationships between platelets and coagulation factors in hemostasis.
    Majerus PW; Miletich JP
    Annu Rev Med; 1978; 29():41-9. PubMed ID: 348040
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of human blood platelets in prothrombin and in factor X activation induced by ionophore A23187.
    van Rijn J; Rosing J; van Dieijen G
    Eur J Biochem; 1983 Jun; 133(1):1-10. PubMed ID: 6406226
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of prothrombin activation on platelets by endothelial cells and mechanism of activation of factor V.
    Rodgers GM; Shuman MA
    Thromb Res; 1987 Jan; 45(2):145-52. PubMed ID: 3563980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.
    Tracy PB; Giles AR; Mann KG; Eide LL; Hoogendoorn H; Rivard GE
    J Clin Invest; 1984 Oct; 74(4):1221-8. PubMed ID: 6480825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human prothrombin-activating enzyme.
    Deggeller K; Vreeken J
    Thromb Diath Haemorrh; 1969 Aug; 22(1):45-67. PubMed ID: 5821247
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence that endotoxins enhance the factor X activator activity of washed human platelets.
    Semerraro N; Fumarola D; Mertens F; Vermylen J
    Br J Haematol; 1978 Feb; 38(2):243-9. PubMed ID: 638073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of bovine coagulation factor Xa to platelets.
    Dahlbäck B; Stenflo J
    Biochemistry; 1978 Nov; 17(23):4938-45. PubMed ID: 718867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of coagulation factor Xa with human platelets.
    Miletich JP; Jackson CM; Majerus PW
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4033-6. PubMed ID: 333455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aggregation and release on platelet prothrombin-converting activity.
    Cox AC; Inyangetor P; Esmon CT; White BN
    Blood; 1979 Sep; 54(3):659-72. PubMed ID: 465734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor X.
    Jackson CM
    Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of interaction between a phosphoinositide anticoagulant and a phospholipid activator in the Stypven type conversion of prothrombin to thrombin.
    Kahn MJ; Bourgain RH
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):273-6. PubMed ID: 4296603
    [No Abstract]   [Full Text] [Related]  

  • 16. The interaction of human coagulation factor Va with platelets.
    Kane WH; Majerus PW
    J Biol Chem; 1982 Apr; 257(7):3963-9. PubMed ID: 7061520
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
    Lisman T; Adelmeijer J; Cauwenberghs S; Van Pampus EC; Heemskerk JW; De Groot PG
    J Thromb Haemost; 2005 Apr; 3(4):742-51. PubMed ID: 15842358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation: a cybernetic system.
    Seegers WH
    Ser Haematol; 1973; 6(4):549-78. PubMed ID: 4277382
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of coagulation factor V with the platelet cytoskeleton.
    Tuszynski GP; Walsh PN; Piperno JR; Koshy A
    J Biol Chem; 1982 Apr; 257(8):4557-63. PubMed ID: 7068650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
    Suzuki K
    Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.